LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 2 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 2. - Dataset (ID:20310)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Neratinib | 0.0013333 | 80.88 | 17.25 | 11137 | 5826 | 1.9116 | 1.1604 | MN20160310_N02 | F06 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0013333 | 82.85 | 17.25 | 766 | 5861 | 0.1307 | 0.5701 | MN20160310_N02 | E03 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0013333 | 82.85 | 17.25 | 9627 | 5861 | 1.6424 | 1.1216 | MN20160310_N02 | E03 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0013333 | 82.85 | 17.25 | 64 | 5861 | 0.0109 | 0.1687 | MN20160310_N02 | F06 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0013333 | 82.85 | 17.25 | 11331 | 5861 | 1.9331 | 1.1631 | MN20160310_N02 | F06 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0013333 | 84.82 | 17.25 | 403 | 5924 | 0.0680 | 0.4536 | MN20160310_N02 | E03 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0013333 | 84.82 | 17.25 | 9803 | 5924 | 1.6548 | 1.1232 | MN20160310_N02 | E03 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0013333 | 84.82 | 17.25 | 33 | 5924 | 0.0056 | 0.0800 | MN20160310_N02 | F06 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0013333 | 84.82 | 17.25 | 11594 | 5924 | 1.9571 | 1.1659 | MN20160310_N02 | F06 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0013333 | 86.79 | 17.25 | 226 | 6008 | 0.0376 | 0.3562 | MN20160310_N02 | E03 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0013333 | 86.79 | 17.25 | 9762 | 6008 | 1.6248 | 1.1183 | MN20160310_N02 | E03 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0013333 | 86.79 | 17.25 | 14 | 6008 | 0.0023 | -0.0244 | MN20160310_N02 | F06 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0013333 | 86.79 | 17.25 | 11671 | 6008 | 1.9425 | 1.1636 | MN20160310_N02 | F06 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0013333 | 88.76 | 17.25 | 175 | 6047 | 0.0289 | 0.3153 | MN20160310_N02 | E03 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0013333 | 88.76 | 17.25 | 9830 | 6047 | 1.6253 | 1.1183 | MN20160310_N02 | E03 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0013333 | 88.76 | 17.25 | 8 | 6047 | 0.0013 | -0.0869 | MN20160310_N02 | F06 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0013333 | 88.76 | 17.25 | 11865 | 6047 | 1.9618 | 1.1660 | MN20160310_N02 | F06 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0013333 | 90.74 | 17.25 | 115 | 6109 | 0.0188 | 0.2511 | MN20160310_N02 | E03 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0013333 | 90.74 | 17.25 | 9795 | 6109 | 1.6032 | 1.1146 | MN20160310_N02 | E03 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0013333 | 90.74 | 17.25 | 9 | 6109 | 0.0015 | -0.0740 | MN20160310_N02 | F06 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0013333 | 90.74 | 17.25 | 12049 | 6109 | 1.9722 | 1.1670 | MN20160310_N02 | F06 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0013333 | 92.71 | 17.25 | 105 | 6184 | 0.0170 | 0.2372 | MN20160310_N02 | E03 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0013333 | 92.71 | 17.25 | 9694 | 6184 | 1.5676 | 1.1088 | MN20160310_N02 | E03 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0013333 | 92.71 | 17.25 | 1 | 6184 | 0.0002 | -0.2851 | MN20160310_N02 | F06 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0013333 | 92.71 | 17.25 | 12185 | 6184 | 1.9704 | 1.1664 | MN20160310_N02 | F06 |